May 22, 2018 7:49 PM ET

Healthcare Providers and Services

Company Overview of Dagze Sailekang Medical Treatment Investment Management Co., Ltd

Key Executives for Dagze Sailekang Medical Treatment Investment Management Co., Ltd

NameBoard RelationshipsTitleAge
There is no Key Executives data available.

Dagze Sailekang Medical Treatment Investment Management Co., Ltd Board Members*

NameBoard RelationshipsPrimary CompanyAge
There is no Board Members data available.

Dagze Sailekang Medical Treatment Investment Management Co., Ltd Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
502.6K
Bonus
407.9K
Total Short Term Compensation
525.6K
Total Value of Options
9.0M
Compensation as of Fiscal Year
Dagze Sailekang Medical Treatment Investment Management Co., Ltd CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Aurora Diagnostics Promotes Bruce Walton as President and COO
May 11, 2018 1:00 PM ET
Héma-Québec Appoints Benoit Morin as President and Chief Executive Officer Effective June 4
May 10, 2018 3:35 PM ET
Jackson Healthcare Names Leslie Day-Harrell as Senior Vice President, Corporate Real Estate
May 10, 2018 3:00 PM ET
Diplomat Pharmacy, Inc. Appoints Brian Griffin as Chief Executive Officer and Chairman of the Board, Effective June 4, 2018
May 10, 2018 12:35 PM ET
Eye Health America Appoints Cathleen McCabe as Chief Medical Officer
May 09, 2018 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dagze Sailekang Medical Treatment Investment Management Co., Ltd, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.